Referenced - Jonathan Weissman - Examining the Media's Medical Mismarketing - Media and Manipulation

1. Forster V. Covid-19 Vaccines Can’t Alter Your DNA, Here’s Why. Forbes. January 11, 2021. Accessed June 11, 2022.

2. Park JW, Lagniton PNP, Liu Y, Xu RH. mRNA vaccines for COVID-19: what, why and how. Int J Biol Sci. 2021; 17(6):1446-1460. doi:10.7150/ijbs.59233

3. Javier T. Granados-Riveron, Guillermo Aquino-Jarquin, Engineering of the current nucleoside-modified mRNA-LNP vaccines against SARS-CoV-2. Biomed. Pharmacother. 2021;142,111953. doi:10.1016/j.biopha.2021.111953

4. Kim SC, Sekhon SS, Shin WR, et al. Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency. Mol Cell Toxicol. 2022;18(1):1-8. doi:10.1007/s13273-021-00171-4

5. Röltgen K, Nielsen SCA, Silva O, et al. Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination. Cell. 2022;185(6):1025-1040.e14. doi:10.1016/j.cell.2022.01.018

6. Bansal S, Perincheri S, Fleming T, et al. Cutting Edge: Circulating Exosomes with COVID Spike Protein Are Induced by BNT162b2 (Pfizer-BioNTech) Vaccination prior to Development of Antibodies: A Novel Mechanism for Immune Activation by mRNA Vaccines. J Immunol. 2021;207(10):2405-2410. doi:10.4049/jimmunol.2100637

7. Advance Purchase Agreement: European Commission and Pfizer-BioNTech. Published April 17, 2021. Accessed June 11, 2022.

8. Assessment Report: Comirnaty. Committee for Medicinal Products for Human Use (CHMP). Published February 19, 2021. Accessed June 11, 2022.

9. Chen T-H, Potapov V, Dai N, Ong JL, Roy B. Improving the fidelity of uridine analog incorporation during in vitro transcription. bioRxiv: the preprint server for biology. Published online April 13, 2022. doi:10.1101/2022.04.12.488100

10. Mauro, VP. Codon Optimization in the Production of Recombinant Biotherapeutics: Potential Risks and Considerations. BioDrugs. 2018; 32:69-81. doi:10.1007/s40259-018-0261-x

11. Plotkin JB, Kudla G. Synonymous but not the same: the causes and consequences of codon bias. Nat Rev Genet. 2011;12(1):32-42. doi:10.1038/nrg2899

12. Wu, M, Tinoco Jr, I. RNA folding causes secondary structure rearrangement. Proc. Natl. Acad. Sci. U.S.A.. 1998;95(20):11555-11560. doi:10.1073/pnas.95.20.11555

13. McKernan K, Kyriakopoulos, A, McCullough, P. Differences in Vaccine and SARS-CoV-2 Replication Derived mRNA: Implications for Cell Biology and Future Disease. 2021. doi:10.31219/

14. ProImmune thinkpeptides. Katerina Alexaki: Effects of codon optimization on biotherapeutics: Implications for immunogenicity. Published September 27, 2019. Accessed June 11, 2022.

15. Slater, J, Westbrook C. Who will get a Covid booster jab and when will boosters start being rolled out? Metro. September 16, 2021. Accessed June 11, 2022.

16. Ambati BK, Varshney A, Lundstrom K, et al. MSH3 Homology and Potential Recombination Link to SARS-CoV-2 Furin Cleavage Site. Front. Virol. 2022;2. doi:10.3389/fviro.2022.834808

17. Hossain MG, Tang Y-d, Akter S, Zheng C. Roles of the polybasic furin cleavage site of spike protein in SARS-CoV-2 replication, pathogenesis, and host immune responses and vaccination. J Med Virol. 2022;94:1815-1820. doi:10.1002/jmv.27539

18. Skopec R. Coronavirus is a Biological Warfare Weapon. J Clin Med Case Rep. 2020;1(2):1-6. doi:10.24966/CSMC-8801/100103

19. Cheng MH, Zhang S, Porritt RA, et al. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation. Proc. Natl. Acad. Sci. U.S.A.. 2020;117(41):25254-25262. doi:10.1073/pnas.2010722117

20. Macphail S. Superantigens: mechanisms by which they may induce, exacerbate and control autoimmune diseases. Int Rev Immunol. 1999;18(1-2):141-180. doi:10.3109/08830189909043022

21. Perez JC, Moret-Chalmin C, Montagnier L. Towards the emergence of a new form of the neurodegenerative Creutzfeldt-Jakob disease: Twenty six cases of CJD declared a few days after a COVID-19 “vaccine” Jab. 2022. doi:10.13140/RG.2.2.12035.37924

22. Prion Diseases. John Hopkins Medicine. Accessed June 11, 2022.

23. Gallagher J. Covid vaccine: What you need to know about vaccine safety. BBC. December 9, 2020. Accessed June 11, 2022.

24. Healy D. Disappeared in Argentina. Accessed June 11, 2022.

25. 125742_S1_M5_5351_c4591001-fa-interim-adverse-events. Pfizer. Accessed June 11, 2022.

26. BNT162b2: Vaccines and Related Biological Products Advisory Committee October 26, 2021 Meeting Document. VRBPAC. Accessed June 11, 2022.

27. Signal assessment report on Myocarditis, pericarditis with Tozinameran (COVID-19 mRNA vaccine (nucleosidemodified) – COMIRNATY). EMA. December 2, 2021. Accessed June 11, 2022.

28. Comirnaty (COVID-19 mRNA Vaccine) Risk Management Plan V.5.0. EMA. Accessed June 11, 2022.

29. Weissman J. Who regulates the regulator? Heart Publications. April 2, 2022. Accessed June 11, 2022.

30. CBER assessment of a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine (0.3 mL) administered to individuals 16 to 17 years of age after completion of a primary vaccination series with the Pfizer-BioNTech COVID-19 Vaccine or COMIRNATY. FDA. December 8, 2021. Accessed June 11, 2022.

31. Perez JL. Efficacy & Safety of BNT162b2 booster - C4591031 2 month interim analysis. November 19, 2021. Accessed June 11, 2022.

32. Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and Efficacy of the BNT162b2 Covid-19 Vaccine in Adolescents. N Engl J Med. 2021;385(3):239-250. doi:10.1056/NEJMoa2107456

33. Antibody Testing Is Not Currently Recommended to Assess Immunity After COVID-19 Vaccination: FDA Safety Communication. FDA. May 19, 2021. Accessed June 11, 2022.

34. (.xpt). Pfizer. Accessed June 11, 2022.

35. Understanding cycle threshold (Ct) in SARS-CoV-2 RT-PCR. Public Health England. October 2020. Accessed June 11, 2022.

36. As Pressure Mounts, Help the NHS by Getting Boosted Now. Cheshire Clinical Commissioning Group. January 10, 2022. Accessed June 11, 2022.

37. Covid: Television advert launched urging people aged 50 and under to get vaccine. ITV. April 25, 2021. Accessed June 11, 2022.

38. Gundry SR. Abstract 10712: Observational Findings of PULS Cardiac Test Findings for Inflammatory Markers in Patients Receiving mRNA Vaccines. Circulation. 2021;144:A10712. doi:10.1161/circ.144.suppl_1.10712

39. PULs – Test Result Package – v4. PULs Cardiac Test. August 15, 2009. Accessed June 11, 2022.

40. Bhakdi S, Burkhardt A. On COVID vaccines: why they cannot work, and irrefutable evidence of their causative role in deaths after vaccination. December 15, 2021. Accessed June 11, 2022.

41. Gong S, Ruprecht RM. Immunoglobulin M: An Ancient Antiviral Weapon – Rediscovered. Front. Immunol. 2020;11. doi:10.3389/fimmu.2020.01943

42. Hoffmann M, Krüger N, Schulz S, et al. The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemic. Cell. 2022;185(3):447-456.e11. doi:10.1016/j.cell.2021.12.032

43. Antibody Essentials Part 1: Antibody Basics. Cell Signal Technology (official blog). Accessed June 11, 2022.

44. Genomic epidemiology of SARS-CoV-2 with subsampling focused globally over the past 6 months. Nextstrain. Accessed June 11, 2022.

45. Guerin P, Yahi N, Azzaz F, et al. Distinct evolution of infection-enhancing and neutralizing epitopes in the spike protein of SARSCoV-2 variants (alpha, beta, gamma, delta, lambda and mu) : a structural and molecular epidemiology. November 8, 2021. doi:10.21203/

46. Dumphreys L, Alvares D. Brazil city offers COVID shots to all 18-60 as part of test. AP News. May 16, 2021. Accessed June 11, 2022.

47. Worshiping the Golden Calf. Wikimedia Commons. Accessed June 11, 2021.